CoChat
Sign Up
Cited by 9Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchBone health and treatments

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma

Huang, Shang-Xiao, Luo, Peng-Hui, Wang, Han-Lei, Mo, Dun-Chang, Huang, Jian-Feng·2023·Journal of Clinical Oncology
DOI 10.1200/jco.22.02665
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1200/jco.22.02665

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 4

  1. 10.1016/S0140-6736(19)31240-1 · DOI
  2. 10.1056/NEJMoa1606038 · DOI · Paper page
  3. 10.1016/S1470-2045(21)00128-5 · DOI · Paper page
  4. 10.1200/JCO.21.02734 · DOI

Cited by

Sorted by citations

See all 9

Metadata

Authors
Huang, S.-X., Luo, P.-H., Wang, H.-L., Mo, D.-C., & Huang, J.-F.
Affiliations
  • The Second Nanning People's Hospital (CN)
  • Shang-Xiao Huang, MD, Peng-Hui Luo, MD, Han-Lei Wang, MD, Dun-Chang Mo, MD, and Jian-Feng Huang, MD, Radiotherapy Department, Nanning Second People's Hospital, Nanning, Guangxi, China
ORCID
Venue
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Published
2023-05-10
Volume
41
Issue
14
Pages
2667-2668
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
DOI
10.1200/jco.22.02665
OpenAlex
W4327908868
Cited by
9
References
1
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 3
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
daratumumab, bortezomib, dexamethasone, multiple myeloma, combination therapy, proteasome inhibitors, monoclonal antibodies
MeSH terms
Bortezomib, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Dexamethasone, Humans, Multiple Myeloma, Neoplasm Recurrence, Local

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma. https://app.cochat.ai/papers/10.1200/jco.22.02665
The paper
Huang, S.-X., Luo, P.-H., Wang, H.-L., Mo, D.-C., & Huang, J.-F. (2023). Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.22.02665